跳转至内容
Merck
CN

SML1075

Sigma-Aldrich

Atglistatin 抑制剂

≥98% (HPLC), powder, adipose triglyceride lipase inhibitor

别名:

3-(4'-(二甲氨基)-[1,1'-联苯] -3-基)-1,1-二甲基脲

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C17H21N3O
分子量:
283.37
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77

产品名称

Atglistatin 抑制剂, ≥98% (HPLC)

质量水平

方案

≥98% (HPLC)

表单

powder

颜色

white to beige

溶解性

DMSO: 20 mg/mL, clear

储存温度

2-8°C

SMILES字符串

CN(C)C(NC1=CC=CC(C2=CC=C(N(C)C)C=C2)=C1)=O

InChI

1S/C17H21N3O/c1-19(2)16-10-8-13(9-11-16)14-6-5-7-15(12-14)18-17(21)20(3)4/h5-12H,1-4H3,(H,18,21)

InChI key

AWOPBSAJHCUSAS-UHFFFAOYSA-N

应用

阿格列汀是一种选择性助理甘油三酯胺酶抑制剂。

生化/生理作用

Atglistatin 是第一个选择性抑制脂肪甘油三酯脂肪酶 (ATGL) 的药物,ATGL 是参与从细胞甘油三酯储存库动员脂肪酸的限速酶。在大肠埃希菌中,Atglistatin 的IC50为0.7μM,对单甘油脂肪酶(MGL)、激素敏感性脂肪酶(HSL)或胰脂肪酶和脂蛋白脂肪酶PNPLA6和PNPLA7无活性。ATGL从细胞甘油三酸酯储存物中生成二酰基甘油,然后被激素敏感性脂肪酶(HSL)和甘油单酸酯脂肪酶降解为甘油和脂肪酸,从而促进了与胰岛素抵抗发展有关的脂毒性代谢产物的合成。 研究表明,Atglistatin抑制ATGL可减少“体外”“体内”的脂肪酸动员

其他说明

产品由格拉茨大学/格拉茨技术大学授权生产。

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Phosphorylation of Beta-3 adrenergic receptor at serine 247 by ERK MAP kinase drives lipolysis in obese adipocytes.
Hong S, et al.
Molecular Metabolism (2018)
Junichiro Mitsui et al.
The Journal of reproduction and development, 70(2), 72-81 (2024-02-05)
After pregnancy, the corpus luteum (CL) functions as a transient endocrine gland that produces progesterone, which is necessary to maintain pregnancy. To maintain constant progesterone production, CLs are enriched in lipids as its precursors. Lipid droplets (LDs) are organelles that
Xu Xiao et al.
Nature metabolism, 5(1), 165-181 (2023-01-17)
In cell models, changes in the 'accessible' pool of plasma membrane (PM) cholesterol are linked with the regulation of endoplasmic reticulum sterol synthesis and metabolism by the Aster family of nonvesicular transporters; however, the relevance of such nonvesicular transport mechanisms
Xirui Liu et al.
Molecular cancer, 17(1), 90-90 (2018-05-17)
Abnormal metabolism, including abnormal lipid metabolism, is a hallmark of cancer cells. Some studies have demonstrated that the lipogenic pathway might promote the development of hepatocellular carcinoma (HCC). However, the role of the lipolytic pathway in HCC has not been
Kacey J Prentice et al.
Journal of lipid research, 64(6), 100386-100386 (2023-05-13)
Levels of circulating fatty acid binding protein 4 (FABP4) protein are strongly associated with obesity and metabolic disease in both mice and humans, and secretion is stimulated by β-adrenergic stimulation both in vivo and in vitro. Previously, lipolysis-induced FABP4 secretion was found

商品

Discover Bioactive Small Molecules for Lipid Signaling Research

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门